Cantor Fitzgerald analyst reiterates Pfizer (NYSE:PFE) with a OverweightBy legume / March 1, 2024 / Pfizer Cantor Fitzgerald analyst Louise Chen reiterates Pfizer (NYSE:PFE) with a Overweight and maintains $45 price target.